Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial
Overview
Authors
Affiliations
Purpose: Randomized controlled trials have supported integrated oncology and palliative care (PC); however, optimal timing has not been evaluated. We investigated the effect of early versus delayed PC on quality of life (QOL), symptom impact, mood, 1-year survival, and resource use.
Patients And Methods: Between October 2010 and March 2013, 207 patients with advanced cancer at a National Cancer Institute cancer center, a Veterans Affairs Medical Center, and community outreach clinics were randomly assigned to receive an in-person PC consultation, structured PC telehealth nurse coaching sessions (once per week for six sessions), and monthly follow-up either early after enrollment or 3 months later. Outcomes were QOL, symptom impact, mood, 1-year survival, and resource use (hospital/intensive care unit days, emergency room visits, chemotherapy in last 14 days, and death location).
Results: Overall patient-reported outcomes were not statistically significant after enrollment (QOL, P = .34; symptom impact, P = .09; mood, P = .33) or before death (QOL, P = .73; symptom impact, P = .30; mood, P = .82). Kaplan-Meier 1-year survival rates were 63% in the early group and 48% in the delayed group (difference, 15%; P = .038). Relative rates of early to delayed decedents' resource use were similar for hospital days (0.73; 95% CI, 0.41 to 1.27; P = .26), intensive care unit days (0.68; 95% CI, 0.23 to 2.02; P = .49), emergency room visits (0.73; 95% CI, 0.45 to 1.19; P = .21), chemotherapy in last 14 days (1.57; 95% CI, 0.37 to 6.7; P = .27), and home death (27 [54%] v 28 [47%]; P = .60).
Conclusion: Early-entry participants' patient-reported outcomes and resource use were not statistically different; however, their survival 1-year after enrollment was improved compared with those who began 3 months later. Understanding the complex mechanisms whereby PC may improve survival remains an important research priority.
Shared decision making in routine oncology appointments with Black patients with lung cancer.
AuBuchon K, Khoudary A, Rodriguez J, Billini O, Westervelt I, Taylor E Support Care Cancer. 2025; 33(4):250.
PMID: 40042631 DOI: 10.1007/s00520-025-09300-4.
Yang G, Ke Y, Ng X, Neo P, Cheung Y Support Care Cancer. 2025; 33(3):249.
PMID: 40038129 DOI: 10.1007/s00520-025-09311-1.
The Role of Specialty Palliative Care in Elective Surgical Oncology: A Systematic Review.
Walsh A, Guo M, Leuschner T, Ejaz A, Pawlik T, Wells-Di Gregorio S Ann Surg Oncol. 2025; .
PMID: 40000563 DOI: 10.1245/s10434-025-17076-4.
Sitter K, Gamboa J, de Groot J Curr Oncol. 2025; 32(2).
PMID: 39996861 PMC: 11854169. DOI: 10.3390/curroncol32020061.
Algorithm-Based Palliative Care in Patients With Cancer: A Cluster Randomized Clinical Trial.
Parikh R, Ferrell W, Li Y, Chen J, Bilbrey L, Johnson N JAMA Netw Open. 2025; 8(2):e2458576.
PMID: 39982729 PMC: 11846008. DOI: 10.1001/jamanetworkopen.2024.58576.